Houston, Texas and Tuebingen, Germany, May 13, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...